Preddict.AI Addiction Treatment Solutions With DHEA
Empower Lasting Recovery with Cutting-Edge Solutions
Find lasting freedom from addiction
For decades there have been no advancements made in the addiction recovery space. Finally a breakthrough has been made!!!
Our revolutionary new tool for addiction treatment combines the technology of AI with leading medical research to aid rehab facilities in breaking the cycle of addiction.
Accurately and effectively predict and understand the chances of a successful rehab and the severity with which a relapse may occur.
Receive individual tailored dosage recommendations to enhance your rehab success by 3x normal rates.
Find out how combining our DHEA program into your rehab can help free you from the prison of addiction.
For decades there have been no advancements made in the addiction recovery space. Finally a breakthrough has been made!!!
Our revolutionary new tool for addiction treatment combines the technology of AI with leading medical research to aid rehab facilities in breaking the cycle of addiction.
Accurately and effectively predict and understand the chances of a successful rehab and the severity with which a relapse may occur.
Receive individual tailored dosage recommendations to enhance your rehab success by 3x normal rates.
Find out how combining our DHEA program into your rehab can help free you from the prison of addiction.
Why Add Our DHEA Program To Your Treatment?
- Reduces drug cravings by up to 60% in human trials
- 3X higher abstinence rates compared in 6-month study
- Prevention of relapse for over 12 months post-treatment
- Precision dosing tailored to individual response
- Normalizes key neurotransmitters disrupted by addiction
- Extinguishes conditioned drug-seeking behaviors
- Restores balance in stress response systems
- Improves impulse control and decision-making
- Non-toxic natural hormone supplement
- Enhances efficacy of counseling when used as a combined tool
Who's Behind The DHEA Research?
This ground breaking new research has been led by a collaborative effort spanning psychiatry, neuroscience, pharmacology, and addiction treatment disciplines across institutions in the US, Israel, and Europe. Both preclinical animal and human clinical trials have contributed to the findings.
Bar-Ilan University, Israel – Gal Yadid, Rimma Maayan, Gispan-Herman Institute – Preclinical animal studies on DHEA’s effects on drug reinstatement and relapse behaviors.
Harvard Medical School – Lothar Buydens-Branchey – Research on DHEA, cortisol, and cocaine addiction.
NIDA Intramural Research Program – Steven Shoptaw – Pilot study on DHEA for cocaine dependence.
University of Cagliari, Italy – Walter Fratta, Elliot Weizman – Human trials of DHEA in opioid addicts undergoing detoxification.
Retorno and Malkishua Rehabilitation Centers, Israel – Multiple human trials of DHEA effects on relapse rates and decision-making.
Tel Aviv Sourasky Medical Center – Neuroimaging studies predicting relapse based on brain activity during DHEA treatment.
University of Georgia – Nicholas Goeders – Animal studies on DHEA’s effects on drug self-administration.
University of Mississippi – Christopher McCurdy – DHEA effects on opioid dependence behaviors.
Our Team
Rabbi Eitan Eckstein is one of the world’s foremost experts on addiction. In 1989 he founded Retorno, Psycho-Educational Center for Addiction Rehabilitation in Mexico, and later in Israel. He holds a Master’s Degree in Social Work (Bar Ilan University). He also completed courses in Arbitration (Bar Ilan University), Therapeutic Horseback Riding (Rupin College), AA Administration (Elka Joint), and is a 12 Steps Practitioner (Anti-Drug Authority and Welfare Ministry). Rabbi Eckstein sits on the Israel Board of Addiction Professionals, and is a member of the Committee of the Ministry of Social Affairs for the treatment of youth at risk.
Prof. Gal Yadid holds a D.Sc. in Neuropharmacology (Bruce Rappaport Faculty of Medicine, Technion), an M.Sc. in Neurobiology and Basic Medical Sciences (Hebrew University), and a B.Sc. in Biology (Hebrew University). He is a Professor in the Faculty of Life Science and the head of the Laboratory of Neuropsychopharmacology in the Brain center at Bar-Ilan University. He has chaired many important committees on Neuroscience and Psychobiology and has participated extensively in pharmacological research, particularly in the areas of depression, PTSD, and addiction, with an emphasis on the use of DHEA in the treatment of addiction. He has published over 100 research studies and has been awarded special recognition for scientific contribution by the Israel Society for Biological Psychiatry and the Eur. Neuropsychoparmacol Society and won the Annual Prize of the Israel Society for Biological Psychiatry.
Izik Zollman is the Administrative Director of Retorno. He served for 25 years in the IDF, reaching the rank of lieutenant colonel. Together with Rabbi Eitan Eckstein, he founded Retorno Psycho-Educational Center for Addiction Rehabilitation, first in Mexico and then in Israel. Izik has a B.A. in general history (University of Tel Aviv).
Have Questions?